Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-012920
Filing Date
2017-05-11
Accepted
2017-05-11 20:21:05
Documents
2
Period of Report
2017-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6473
2 EX-24 DOCUMENT attachment1.htm EX-24 4179
  Complete submission text file 0000899243-17-012920.txt   12116
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Issuer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 19900 MACARTHUR BLVD., SUITE 550 IRVINE CA 92612
Business Address
TURKEL CATHERINE C. (Reporting) CIK: 0001705278 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36620 | Film No.: 17836071